E. Pianezzola

Phase I and endocrine study of exemestane (FCE 24304), a new aromatase inhibitor, in postmenopausal women.

T.R. Jeffry Evans, E. Di Salle, G. Ornati et al. · PubMed · 1992 · 150 citations

Gynecology, Pharmacotherapy, Reproductive Endocrinology +18

Ratio of the R and S enantiomers of salsolinol in food and human urine

M. Strolin Benedetti, V. Bellotti, E. Pianezzola et al. · Journal of Neural Transmission · 1989 · 70 citations

Human Urine, Biochemistry, Medicine +5

Pharmacokinetics, pharmacodynamics, and tolerability of cabergoline, a prolactin-lowering drug, after administration of increasing oral doses (0.5, 1.0, and 1.5 milligrams) in healthy male volunteers.

A. C. Andreotti, E. Pianezzola, Stefano Persiani et al. · The Journal of Clinical Endocrinology & Metabolism · 1995 · 46 citations

Hypertension, Prl Secretion Areas, Pharmacological Study +11

Absorption, disposition and preliminary metabolic pathway of ¹⁴C-rifabutin in animals and man

R. Battaglia, E. Pianezzola, Giuliana Salgarollo et al. · Journal of Antimicrobial Chemotherapy · 1990 · 40 citations

Faecal Excretion, Faecal Routes, Pharmacotherapy +19

Determination of ethambutol in human plasma and urine by high-performance liquid chromatography with fluorescence detection

Massimo Breda, P. Marrari, E. Pianezzola et al. · Journal of Chromatography A · 1996 · 36 citations

Fluorescence Detection, Gas Chromatography, Medicine +10